The Infection Surveillance Solutions market is witnessing robust growth, fueled by the increasing prevalence of healthcare-associated infections (HAIs) and the need for efficient infection prevention measures in healthcare facilities. According to the CDC, approximately one in 31 hospitalized patients in the U.S. contracts an HAI daily, leading to severe patient safety concerns, extended hospital stays, and higher healthcare costs. Globally, the WHO reports that 7% of patients in high-income countries and 15% in low- and middle-income countries are affected by at least one HAI during their hospital stay.